Resveratrol, human health and winemaking perspectives

References

• Adrian, M., P. Jeandet, A. Douillet-Breuil, L. C. Tesson, and R. Bessis. 2000. Stilbene content of mature Vitis vinifera berries in response to UV-C elicitation. J. Agric. Food Chem. 48:6103–6105.
   PubMed Web of Science ®Google Scholar
• Atanacković, M., A. Petrović, S. Jović, L. Gojković- Bukarica, M. Bursać, and J. Cvejić. 2012. Influence of winemaking techniques on the resveratrol content, total phenolic content and antioxidant potential of red wines. Food Chemistry 131:513–518.
   Web of Science ®Google Scholar
• Anton, S. D., C. Embry, M. Marsiske, X. Lu, H. Doss, C. Leeuwenburgh, and T. M. Manini. 2014. Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study. Exp. Gerontol. 57:181–187.
   PubMed Web of Science ®Google Scholar
• Barja, G. 2014. The mitochondrial free radical theory of aging. Prog Mol Biol Transl Sci. 127:1–27.
   PubMed Web of Science ®Google Scholar
• Bavaresco, L., F. Mattivi, and R. Flamini. 2012. Effects of elicitors, viticultural factors, and enological practices on resveratrol and stilbenes in grapevine and wine. Mini Rev Med Chem. 12:1366–1381.
   PubMed Web of Science ®Google Scholar
• Baur, J. A., K. J. Pearson, N. L. Price, H. A. Jamieson, C. Lerin, A. Kalra, V. V. Prabhu, J. S. Allard, G. Lopez-Lluch, K. Lewis, P. J. Pistell, S. Poosala, K. G. Becker, O. Boss, D. Gwinn, M. Wang, S. Ramaswamy, K. W. Fishbein, R. G. Spencer, E. G. Lakatta, D. Le Couteur, R. J. Shaw, P. Navas, P. Puigserver, D. K. Ingram, R. de Cabo, and D. A. Sinclair. 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337–342.
   PubMed Web of Science ®Google Scholar
• Bhatt, J. K., S. Thomas, and M. J. Nanjan. 2012. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res. 32:537–541.
   PubMed Web of Science ®Google Scholar
• Birrell, M. A., K. McCluskie, S. Wong, L. E. Donnelly, P. J. Barnes, and M. G. Belvisi. 2005. Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. FASEB J. 19:840–841.
   PubMed Web of Science ®Google Scholar
• Blaut, M., and T. Clavel. 2007. Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr. 137:751S–755S.
   PubMed Web of Science ®Google Scholar
• Bo, S., G. Ciccone, A. Castiglione, R. Gambino, F. De Michieli, P. Villois, M. Durazzo, P. Cavallo-Perin, and M. Cassader. 2013. Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Curr Med Chem. 20:1323–31.
   PubMed Web of Science ®Google Scholar
• Boocock, D. J., G. E. Faust, K. R. Patel, A. M. Schinas, V. A. Brown, M. P. Ducharme, T. D. Booth, J. A. Crowell, M. Perloff, A. J. Gescher, W. P. Steward, and D. E. Brenner. 2007. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 16:1246–1252.
   PubMed Web of Science ®Google Scholar
• Boveris, A. 2004. Radicales libres y antioxidantes en salud Humana. In Dietas Mediterráneas. La evidencia científica, Eds. F., Leighton Puga and I., UrquiagaReus. Pontificia Universidad Católica de Chile. ISBN 956-14-0793-0.
   Google Scholar
• Boveris, A., N. Oshino, and B. Chance. 1972. The cellular production of hydrogen peroxide. Biochem. J. 128:617–630.
   PubMed Web of Science ®Google Scholar
• Boveris, A. 2005. La evolución del concepto de radicales libres en biología y medicina. Ars Pharm. 46:85–95.
   Google Scholar
• Brasnyó, P., G. A. Molnár, M. Mohás, L. Markó, B. Laczy, J. Cseh, E. Mikolás, I. A. Szijártó, A. Mérei, R. Halmai, L. G. Mészáros, B. Sümegi, and I. Wittmann. 2011. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr. 106:383–9.
   PubMed Web of Science ®Google Scholar
• Brown, V. A., K. R. Patel, M. Viskaduraki, J. A. Crowell, M. Perloff, T. D. Booth, G. Vasilinin, A. Sen, A. M. Schinas, G. Piccirilli, K. Brown, W. P. Steward, A. J. Gescher, and D. E. Brenner. 2010. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. 70:9003–11.
   PubMed Web of Science ®Google Scholar
• Cantó, C., and J. Auwerx. 2012. Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?. Pharmacol Rev. 64:166–187.
   PubMed Web of Science ®Google Scholar
• Carter, L. G., J. A. D'Orazio, and K. J. Pearson. 2014. Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer. 21:209–25.
   PubMed Web of Science ®Google Scholar
• Chachay, V. S., G. A. Macdonald, J. H. Martin, J. P. Whitehead, T. M. O'Moore-Sullivan, P. Lee, M. Franklin, K. Klein, P. J. Taylor, M. Ferguson, J. S. Coombes, G. P. Thomas, G. J. Cowin, C. M. Kirkpatrick, J. B. Prins, and I. J. Hickman. 2014. Resveratrol does not benefit patients with non-alcoholic fatty liver disease. Clin. Gastroenterol Hepatol. 12:2092–103.
   PubMed Web of Science ®Google Scholar
• Chen, S., X. Zhao, L. Ran, J. Wan, X. Wang, Y. Qin, F. Shu, Y. Gao, L. Yuan, Q. Zhang, and M. Mi. 2015. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Dig Liver Dis. 47:226–232.
   PubMedGoogle Scholar
• Chow, H. H., L. L. Garland, C. H. Hsu, D. R. Vining, W. M. Chew, J. A. Miller, M. Perloff, J. A. Crowell, and D. S. Alberts. 2010. Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev Res (Phila). 3:1168–75.
   PubMed Web of Science ®Google Scholar
• Chow, H. H., L. L. Garland, B. M. Heckman-Stoddard, C. H. Hsu, V. D. Butler, C. A. Cordova, W. M. Chew, and T. L. Cornelison. 2014. A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones. J. Transl. Med. 12:223.
   PubMed Web of Science ®Google Scholar
• Cvejic, J., and L. J. Gojkovic-Bukarica. 2016. Wine phenolics: Clinical trials. In Red wine consumption and health, 501–508. Nova Science Publisher, Inc. NOVA.
   Google Scholar
• Crandall, J. P., V. Oram, G. Trandafirescu, M. Reid, P. Kishore, M. Hawkins, H. W. Cohen, and N. Barzilai. 2012. Pilot Study of resveratrol in Older Adults With Impaired Glucose Tolerance. J Gerontol A Biol Sci Med Sci. 67:1307–1312.
   PubMed Web of Science ®Google Scholar
• Das, M., and D. K. Das. 2010. Resveratrol and cardiovascular health. Mol Aspects Med. 31:503–12.
   PubMed Web of Science ®Google Scholar
• Dash, S., C. Xiao, C. Morgantini, L. Szeto, and G. F. Lewis. 2013. High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men. Arterioscler. Thromb. Vasc. Biol. 33:2895–2901.
   PubMed Web of Science ®Google Scholar
• Ector, B. J., J. B. Magee, C. P. Hegwood and M. J. Coign. 1996. Resveratrol concentration in muscadine berries, juice, pomace, purees, seeds, and wines. Am. J. Enol. Vitic. 47:57–62; 1996.
   Web of Science ®Google Scholar
• EFSA. 2017. Overview on Dietary Reference values for the EU population as derived by the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Version 4 (September 2017). Available at: https://www.efsa.europa.eu/sites/default/files/assets/DRV_Summary_tables_jan_17.pdf
   Google Scholar
• Ermakov, I. V., and W. Gellermann. 2010. Validation model for Raman based skin carotenoid detection. Archives of Biochemistry and Biophysics 504:40–49.
   PubMed Web of Science ®Google Scholar
• Evans, H. M., P. R. C. Howe, and R. H. X. Wong. 2016. Clinical evaluation of effects of chronic resveratrol supplementation on cerebrovascular function, cognition, mood, physical function and general well-being in postmenopausal women—rationale and study design. Nutrients. 8:150.
   PubMed Web of Science ®Google Scholar
• Faghihzadeh, F., P. Adibi, R. Rafiei, and A. Hekmatdoost. 2014. Resveratrol supplementation improves inflammatory biomarkers in patients with non alcoholic fatty liver disease. Nutr. Res. 34:837–843.
   PubMed Web of Science ®Google Scholar
• Frankel, E. N., A. L. Waterhouse, and J. E. Kinsella. 1993. Inhibition of human LDL oxidation by resveratrol. Lancet 341:1103–1104.
   PubMed Web of Science ®Google Scholar
• Frankel, E. N., A. L. Waterhouse, and P. L. Teissedre. 1995. Principal phenolic phytochemicals in selected california wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins. J. Agric Food Chem. 43:890–894.
   Web of Science ®Google Scholar
• Fujitaka, K., H. Otani, F. Jo, H. Jo, E. Nomura, M. Iwasaki, M. Nishikawa, T. Iwasaka, and D. K. Das. 2011. Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment. Nutr Res. 31:842–847.
   PubMed Web of Science ®Google Scholar
• Gambini, J., M. Inglés, G. Olaso, R. Lopez-Gueso, V. Bonet-Costa, L. Gimeno-Mallench, C. Mas-Bargues, K. M. Abdelaziz, M. C. Gomez-Cabrera, J. Vina, and C. Borras. 2015. Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxid Med Cell Longev. 2015:837042.
   PubMed Web of Science ®Google Scholar
• Gerschman, R., D. L. Gilbert, S. W. Nye, P. Dwyer, and W. O. Fenn. 1954. Oxygen poisoning and X-irradiation: a mechanism in common. Science 119:623–626.
   PubMed Web of Science ®Google Scholar
• Gliemann, L., J. F. Schmidt, J. Olesen, R. S. Biensø, S. L. Peronard, S. U. Grandjean, S. P. Mortensen, M. Nyberg, J. Bangsbo, H. Pilegaard, and Y. Hellsten. 2013. Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. J Physiol. 591:5047–59.
   PubMed Web of Science ®Google Scholar
• Goh, K. P., H. Y. Lee, D. P. Lau, W. Supaat, Y. H. Chan, and A. F. Y. Koh. 2014. Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure. Int. J. Sport Nutr. Exerc. Metab. 24:2–13.
   PubMed Web of Science ®Google Scholar
• Goldberg, D. M., J. Yan, E. Ng, E. P. Diamandis, A. Karumanchiri, G. Soleas and A. L. Waterhouse. 1995. A global survey of trans-resveratrol concentrations in commercial wines. Am. J. Enol. Vitic. 46:159–165; 1995.
   Web of Science ®Google Scholar
• Goldberg, D. M., J. Yan, and G. J. Soleas. 2003. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 36:79–87.
   PubMed Web of Science ®Google Scholar
• Gualdoni, G. A., J. J. Kovarik, J. Hofer, F. Dose, M. Pignitter, D. Doberer, P. Steinberger, V. Somoza, M. Wolzt, and G. J. Zlabinger. 2014. Resveratrol enhances TNF-alpha production in human monocytes upon bacterial stimulation. Biochem. Biophys Acta. 1840:95–105.
   PubMed Web of Science ®Google Scholar
• Hasan, M. M., and K. H. Baek. 2013. Induction of resveratrol biosynthesis in grape skin and leaves by ultrasonication treatment. Korean J. Hortic. Sci. Technol. 31:496–502.
   Web of Science ®Google Scholar
• Hasan, M. M., H. K. Yun, E. J. Kwak and K. H. Baek. 2014. Preparation of resveratrol-enriched grape juice from ultrasonication treated grape fruits. Ultrason. Sonochem. 21:729–734.
   PubMed Web of Science ®Google Scholar
• He, W., D. Goodkind, and P. Kowal. 2016. U.S. Census Bureau, International Population Reports, P95/16-1, An Aging World: 2015. Washington, DC: U.S. Government Publishing Office. 2016.
   Google Scholar
• Hernández Saavedra, D., and J. M. McCord. 2007. Evolución y radicales libres. Importancia del estrés oxidativo en la patología humana. Rev Med Inst Mex Seguro Soc. 45:477–484.
   PubMedGoogle Scholar
• Howells, L. M., D. P. Berry, P. J. Elliott, E. W. Jacobson, E. Hoffmann, B. Hegarty, K. Brown, W. P. Steward, and A. J. Gescher. 2011. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases-safety, pharmacokinetics, and pharmacodynamics. Cancer Prev. Res. (Phila) 4:1419–25.
   PubMed Web of Science ®Google Scholar
• Jang, M., L. Cai, G. O. Udeani, K. V. Slowing, C. F. Thomas, C. W. Beecher, H. H. Fong, N. R. Farnsworth, A. D. Kinghorn, R. G. Mehta, R. C. Moon, and J. M. Pezzuto. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218–220.
   PubMed Web of Science ®Google Scholar
• Jeandet, P., R. Bessis, B. F. Maume, P. Meunier, D. Peyron and P. Trollat. 1995a. Effect of enological practices on the resveratrol isomer content of wine. J. Agric. Food Chem. 43:316–319.
   Web of Science ®Google Scholar
• Jeandet, P., R. Bessis, M. Sbaghi, P. Meunier, and P. Trollat. 1995b. Resveratrol content of wines of different ages: relationship with fungal disease pressure in the vineyard. Am. J. Enol. Vitic. 46:1–4.
   Web of Science ®Google Scholar
• JECFA. 2003. Diet, nutrition and prevention of chronich diseases: report of a Joint WHO/FAO Expert consultation. WHO Technical Report Series, n. 916, WHO, Geneve.
   Google Scholar
• Karatzi, K., C. Papamichael, E. Karatzis, T. G. Papaioannou, P.Th. Voidonikola, G. D. Vamvakou, J. John Lekakis, and A. Zampelas. 2008. Postprandial Improvement of Endothelial Function by Red Wine and Olive Oil Antioxidants: A Synergistic Effect of Components of the Mediterranean Diet. Journal of the American College of Nutrition 27:448–453.
   PubMed Web of Science ®Google Scholar
• Kennedy, D. O., E. L. Wightman, J. L. Reay, G. Lietz, E. J. Okello, A. Wilde, and C. F. Haskell. 2010. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am J Clin Nutr. 91:1590–7.
   PubMed Web of Science ®Google Scholar
• Knop, F. K., E. Konings, S. Timmers, P. Schrauwen, J. J. Holst, and E. E. Blaak. 2013. Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects. Diabet. Med. 30:1214–1218.
   PubMed Web of Science ®Google Scholar
• Konings, E., S. Timmers, M. V. Boekschoten, G. H. Goossens, J. W. Jocken, L. A. Afman, M. Muller, P. Schrauwen, E. C. Mariman, and E. E. Blaak. 2014. The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men. Int. J. Obes. (Lond.). 38:470–473.
   PubMed Web of Science ®Google Scholar
• Kostadinović, S., A. Wilkens, M. Stefova, V. Ivanova, B. Vojnoski, H. Mirhosseini, and P. Winterhalter. 2012. Stilbene levels and antioxidant activity of Vranec and Merlot wines from Macedonia: effect of variety and enological practices. Food Chem. 135:3003–3009.
   PubMed Web of Science ®Google Scholar
• Langcake, P. 1981. Disease resistance of Vitis spp. and the production of the stress metabolites resveratrol, ϵ-viniferin, α-viniferin, and pterostilbene. Physiol. Plant Pathol. 18:213–226.
   Google Scholar
• Lee, S. H., and K. J. Min. 2013. Caloric restriction and its mimetics. BMB Rep. 46:181–7.
   PubMed Web of Science ®Google Scholar
• Lin, C. T., X. Y. Sun, and A. X. Lin. 2016. Supplementation with high-dose trans-resveratrol improves ultrafiltration in peritoneal dialysis patients: a prospective, randomized, double-blind study. Ren Fail. 38:214–21.
   PubMed Web of Science ®Google Scholar
• Magyar, K., R. Halmosi, A. Palfi, G. Feher, L. Czopf, A. Fulop, I. Battyany, B. Sumegi, K. Toth, and E. Szabados. 2012. Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease. Clin Hemorheol Microcirc. 50:179–87.
   PubMed Web of Science ®Google Scholar
• Maher, P. 2005. The effect of stress and aging on glutathione metabolism. Ageing Res Rev. 4:288–314.
   PubMed Web of Science ®Google Scholar
• Maia, H. Jr., C. Haddad, N. Pinheiro, and J. Casoy. 2012. Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain. Int. J. Womens. Health 4:543–549.
   PubMedGoogle Scholar
• Mayne, S. T., B. Cartmel, S. Scarmo, L. Jahns, I. V. Ermakov, and W. Gellermann. 2013. Resonance Raman Spectroscopic evaluation of skin carotenoids as a biomarker of carotenoid status for human studies. Arch Biochem Biophys. 539:163–170.
   PubMed Web of Science ®Google Scholar
• Mendez del Villar, M., M. Gonzalez-Ortiz, E. Martinez-Abundis, K. G. Perez-Rubio, and R. Lizarraga-Valdez. 2014. Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab Syndr. Relat. Disord. 12:497–501.
   PubMed Web of Science ®Google Scholar
• Meng, X., P. Maliakal, H. Lu, M. J. Lee, and C. S. Yang. 2004. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J. Agric. Food Chem. 52:935–942.
   PubMed Web of Science ®Google Scholar
• Militaru, C., I. Donoiu, A. Craciun, I. D. Scorei, A. M. Bulearca, and R. I. Scorei. 2013. Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: Effects on lipid profiles, inflammation markers, and quality of life. Nutrition 29:178–83.
   PubMed Web of Science ®Google Scholar
• Nguyen, A. V., M. Martinez, J. Stamos, M. P. Moyer, K. Planutis, C. Hope, and R. F. Holcombe. 2009. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag. Res. 1:25–37.
   PubMedGoogle Scholar
• Nicholson, J. K., E. Holmes, J. Kinross, R. Burcelin, G. Gibson, W. Jia, and S. Pettersson. 2012. Host-gut microbiota metabolic interactions. Science 336:1262–1267.
   PubMed Web of Science ®Google Scholar
• Olesen, J., L. Gliemann, R. Biensø, J. Schmidt, Y. Hellsten, and H. Pilegaard. 2014. Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men. J. Physiol. 592:1873–1886.
   PubMed Web of Science ®Google Scholar
• Ornstrup, M. J., T. Harsløf, T. N. Kjær, B. L. Langdahl, and S. B. Pedersen. 2014. Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo controlled trial. J. Clin. Endocrinol. Metab. 99:4720–4729.
   PubMed Web of Science ®Google Scholar
• Pastor, R. F., M. R. Gargantini, M. Murgo, S. Prieto, H. Manzano, C. Aruani, C. I. Quini, M. I. Covas, and R. H. Iermoli. 2015. Enrichment of resveratrol in wine through a new vinification procedure. Journal of Life Sciences 9:327–333.
   Google Scholar
• Patel, K. R., V. A. Brown, D. J. Jones, R. G. Britton, D. Hemingway, A. S. Miller, K. P. West, T. D. Booth, M. Perloff, J. A. Crowell, D. E. Brenner, W. P. Steward, A. J. Gescher, and K. Brown. 2010. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 70:7392–7399.
   PubMed Web of Science ®Google Scholar
• Pezet, R., V. Pont, and K. Hoang-Van. 1991. Evidence for oxidative detoxification of pterostilbene and resveratrol by a laccase-like stilbene oxidase produced by Botrytis cinerea Physiological and Molecular Plant Pathology 39:441–450.
   Google Scholar
• Pezet, R., and P. Cuenat. 1996. Resveratrol in wine: extraction from skin during fermentation and post-fermentation standing of must from Gamay grapes. Am. J. Enol. Vitic. 47:287–290; 1996.
   Web of Science ®Google Scholar
• Pisoschi, A. M., and A. Pop. 2015. The role of antioxidants in the chemistry of oxidative stress: a review. Eur. J. Med. Chemistry. 97:55–74.
   PubMed Web of Science ®Google Scholar
• Poulsen, M. M., P. F. Vestergaard, B. F. Clasen, Y. Radko, L. P. Christensen, H. Stødkilde-Jørgensen, N. Møller, N. Jessen, S. B. Pedersen, and J. O. Jørgensen. 2013. High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 62:1186–1195.
   PubMed Web of Science ®Google Scholar
• Preiser, J. C. 2012. Oxidative Stress. Journal of Parenteral and Enteral Nutrition 36:147–154.
   PubMed Web of Science ®Google Scholar
• Rabassa, M., R. Zamora-Ros, M. Urpi-Sarda, and C. Andres-Lacueva. 2015. Resveratrol metabolite profiling in clinical nutrition research—from diet to uncovering disease risk biomarkers: epidemiological evidence. Ann. N.Y. Acad. Sci. 1348:107–115.
   PubMed Web of Science ®Google Scholar
• Raha, S., and B. H. Robinson. 2000. Mitochindria, oxygen free radicals, disease and ageing. TIBS. 25:502–508.
   PubMed Web of Science ®Google Scholar
• Rahal, A., A. Kumar, V. Singh, B. Yadav, R. Tiwari, S. Chakraborty, and K. Dhama. 2014. Oxidative stress, prooxidants and antioxidants: the interplay. Biomed. Res. Int. 2014:761264.
   PubMed Web of Science ®Google Scholar
• Rahman, I., S. K. Biswas, and P. A. Kirkham. 2006. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol. 72:1439–1352.
   PubMed Web of Science ®Google Scholar
• Renaud, S., and M. De Lorgeril. 1992. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339:1523–1526.
   PubMed Web of Science ®Google Scholar
• Revilla, E., E. García-Beneytez, F. Cabello, G. Martín-Ortega, and J. M. Ryan. 2001. Value of high-performance liquid chromatographic analysis of anthocyanins in the differentiation of red grape cultivars and red wines made from them. J. Chromatogr A 915:53–60.
   PubMed Web of Science ®Google Scholar
• Romero-Pérez, A. I., R. M. Lamuela-Raventós, C. Andrés-Lacueva, and M. C. de la Torre-Boronat. 2001. Method for the quantitative extraction of resveratrol and piceid isomers in grape berry skins. Effect of powdery mildew on the stilbene content. J. Agric. Food Chem. 49:210–215.
   PubMed Web of Science ®Google Scholar
• Samiec, P. S., C. Drews-Botsch, E. W. Flagg, J. C. Kurtz, P.Sternberg J.R., R. L. Reed, and D. P. Jones. 1998. Glutathione in human plasma: Decline in association with aging, age-related macular degeneration, and diabetes. Free Radical Biology & Medicine 24:699–704.
   PubMed Web of Science ®Google Scholar
• Samsamikor, M., N. E. Daryani, P. R. Asl, and A. Hekmatdoost. 2016. Resveratrol Supplementation and Oxidative/Anti-Oxidative Status in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study. Arch. Med. Res. 47:304–309.
   PubMed Web of Science ®Google Scholar
• Scribbans, T. D., J. K. Ma, B. A. Edgett, K. A. Vorobej, A. S. Mitchell, J. G. Zelt, C. A. Simp-son, J. Quadrilatero, and B. J. Gurd. 2014. Resveratrol supplementation does not augment performance adaptations or fibre-type-specific responses to high- intensity interval training in humans. Appl. Physiol. Nutr. Metab. 39:1305–1313.
   PubMed Web of Science ®Google Scholar
• Semba, R. D., L. Ferrucci, B. Bartali, M. Urpí-Sarda, R. Zamora-Ros, K. Sun, A. Cherubini, S. Bandinelli, and C. Andres-Lacueva. 2014. Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Intern. Med. 174:1077–1084.
   PubMed Web of Science ®Google Scholar
• Siemann, E. H., and L. L. Creasy. 1992. Concentration of the phytoalexin resveratrol in wine. Am. J. Eno. Vitic. 43:49–52.
   Web of Science ®Google Scholar
• Sies, H. 1985. Oxidative Stress, Eds. H. B., Jovanovich. San Diego: Academic Press.
   Google Scholar
• Soleas, G. J., E. P. Diamandis, and D. M. Goldberg. 1997. Wine as a biological fluid: history, production, and role in disease prevention. J. Clin. Lab. Anal. 11:287–313.
   PubMed Web of Science ®Google Scholar
• Soleas, G. J., G. Yan, and D. M. Goldberg. 2001. Ultra-sensitive assay for three polyphenols (catechin, quercetin and resveratrol) and their conjugates in biological fluids utilizing gas chromatography with mass selective detection. J. Chromatogr. B. 757:161–172.
   PubMed Web of Science ®Google Scholar
• Somers, T. C., and E. Vérette. 1988. Phenolic composition of natural wine types. In Wine analysis, Eds. H. F., Linskens and J. F., Jackson, 219–257, 1988. Berlin Heidelberg: Springer-Verlag.
   Google Scholar
• Spayd, S., J. Tarara. 2002. Separation of sunlight and temperature effects on the composition of Vitis vinifera cv. Merlot berries. Am. J. Enol. Vitic. 3:171–182.
   Google Scholar
• Stockley, C., P.-L. Teissedre, M. Boban, C. Di Lorenzo, and P. Restani. 2012. Bioavailability of wine-derived phenolic compounds in humans: a review. Food & Function 3:995–1007.
   PubMed Web of Science ®Google Scholar
• Stockley, C. S., and D. Johnson. 2015. Adverse food reactions from consuming wine. Australian Journal of Grape and Wine Research 21:568–581.
   Web of Science ®Google Scholar
• Stotland, A., and R. A. Gottlieb. 2015. Mitochondrial quality control: Easy come, easy go. Biochimica et Biophysica Acta 1853:2802–2811.
   PubMed Web of Science ®Google Scholar
• Thazhath, S. S., T. Wu, M. J. Bound, H. L. Checklin, S. Standfield, K. L. Jones, M. Horowitz, and C. K. Rayner. 2016. Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial. Am. J. Clin. Nutr. 103:66–70.
   PubMed Web of Science ®Google Scholar
• Timmer, S., J. Auwerx, and P. Schrauwen. 2012. The journey of resveratrol from yeast to human. Aging 4:1–13.
   PubMedGoogle Scholar
• Timmers, S., E. Konings, L. Bilet, R. H. Houtkooper, T. van de Weijer, G. H. Goossens, J. Hoeks, S. van der Krieken, D. Ryu, S. Kersten, E. Moonen-Kornips, M. K. C. Hesselink, I. Kunz, V. B. Schrauwen-Hinderling, E. Blaak, J. Auwerx, and P. Schrauwen. 2011. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 14:612–622.
   PubMed Web of Science ®Google Scholar
• Tomé-Carneiro, J., M. Gonzalvez, M. Larrosa, F. J. Garcia-Almagro, F. Aviles-Plaza, S. Parra, M. J. Yanez-Gascon, J. A. Ruiz-Ros, M. T. Garcia-Conesa, F. A. Tomas-Barberan, and J. C. Espin. 2012a. Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients under- going primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial. Mol. Nutr. Food Res. 56:810–821.
   PubMed Web of Science ®Google Scholar
• Tomé-Carneiro, J., M. Gonzálvez, M. Larrosa, M. J. Yáñez-Gascón, F. J. García-Almagro, J. A. Ruiz-Ros, M. T. García-Conesa, F. A. Tomás-Barberán, and J. C. Espín. 2012b. One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease. Am. J. Cardiol. 110:356–363.
   PubMed Web of Science ®Google Scholar
• Tomé-Carneiro, J., M. Gonzalvez, M. Larrosa, M. J. Yanez-Gascon, F. J. Garcia-Almagro, J. A. Ruiz-Ros, F. A. Tomas-Barberan, M. T. Garcia-Conesa, and J. C. Espin. 2013a. Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease. Cardiovasc. Drugs Ther. 27:37–48.
   PubMed Web of Science ®Google Scholar
• Tomé-Carneiro, J., M. Larrosa, M. J. Yanez-Gascon, A. Davalos, J. Gil-Zamorano, M. Gonzalvez, F. J. Garcia-Almagro, J. A. Ruiz Ros, F. A. Tomas-Barberan, J. C. Espin, and M. T. Garcia-Conesa. 2013b. One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol. Res. 72:69–82.
   PubMed Web of Science ®Google Scholar
• Turner, R. S., R. G. Thomas, S. Craft, C. H. Van Dyck, J. Mintzer, B. A. Reynolds, J. B. Brewer, R. A. Rissman, R. Raman, and P. S. Aisen. 2015. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology 85:1383–1391.
   PubMed Web of Science ®Google Scholar
• USDA. 2015. Dietary guidelines for Americans 2015–2020, US Department of Health and Human Service and US Department of Agricukture, Eighth Edition, December 2015. Available at: http://health.gov/dietaryguidelines/2015/guidelines/.
   Google Scholar
• Vauzour, D., A. Rodriguez-Mateos, G. Corona, M. J. Oruna-Concha and J. P. E. Spencer. 2010. Polyphenols and human health: Prevention of disease and mechanisms of action. Nutrients 2:1106–1131
   PubMed Web of Science ®Google Scholar
• Vitaglione, P., S. Sforza, G. Galaverna, C. Ghidini, N. Caporaso, P. P. Vescovi, V. Fogliano, and R. Marchelli. 2005. Bioavailability of trans-resveratrol from red wine in humans. Molecular Nutrition and Food Research 49:495–504.
   PubMed Web of Science ®Google Scholar
• Vitrac, X., A. Desmouli`ere, B. Brouillaud, S. Krisa, G. Deffieux, N. Barthe, J. Rosenbaum, and J. M. Mérillon. 2003. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sciences 20:2219–2233.
   Google Scholar
• Voduc, N., C. la Porte, C. Tessier, R. Mallick, and D. W. Cameron. 2014. Effect of resveratrol on exercise capacity: a randomized placebo-controlled crossover pilot study. Appl Physiol Nutr Metab. 39:1183–7.
   PubMed Web of Science ®Google Scholar
• Walle, T., F. Hsieh, M. H. De Legge, J. E. Oatis, and U. K. Walle. 2004. High absorption but very low bioavailability of oral resveratrol in humans. Drug. Metab. Dispos. 32:1377–1382.
   PubMed Web of Science ®Google Scholar
• Waterhouse, A. L. 2002. Wine phenolics. Ann New York Academy of Sciences 957:21–36.
   PubMed Web of Science ®Google Scholar
• Wenzel, E., and V. Somoza. 2005. Metabolism and bioavailability of trans-resveratrol. Molecular Nutrition and Food Research 5:472–481.
   Google Scholar
• Wong, R. H., P. R. Howe, J. D. Buckley, A. M. Coates, I. Kunz, and N. M. Berry. 2011. Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr. Metab. Cardiovasc. Dis. 21:851–856.
   PubMed Web of Science ®Google Scholar
• Wong, R. H., D. Raedestorff, and P. R. Howe. 2016. Acute resveratrol consumption improves neurovascular coupling capacity in adults with type 2 diabetes mellitus. Nutrients 8:425.
   Web of Science ®Google Scholar
• Wu, J. M., and T. C. Hsieh. 2011. Resveratrol: a cardioprotective substance. Ann N Y Acad Sci 1215:16–21.
   PubMed Web of Science ®Google Scholar
• Yoshino, J., C. Conte, L. Fontana, B. Mittendorfer, S. Imai, K. B. Schechtman, C. Gu, I. Kunz, F. Rossi Fanelli, B. W. Patterson, and S. Klein. 2012. Resveratrol supplementation does not improve metabolic function in non obese women with normal glucose tolerance. Cell Metab. 16:658–64.
   PubMed Web of Science ®Google Scholar
• Xue, Y. Q., J. M. Di, Y. Luo, K. J. Cheng, X. Wei, and Z. Shi. 2014. Resveratrol oligomers for the prevention and treatment of cancers. Oxidative Medicine and cellular longevity Vol 2014, Article ID 765832. Available at: https://doi.org/10.1155/2014/765832.
   Google Scholar
• Zamora-Ros, R., M. Urpí-Sardà, R. M. Lamuela-Raventós, R. Estruch, M. Vázquez-Agell, M. Serrano-Martínez, W. Jaeger, and C. Andres-Lacueva. 2006. Diagnostic performance of urinary resveratrol metabolites as a biomarker of moderate wine consumption. Clin. Chem. 52:1373–1380.
   PubMed Web of Science ®Google Scholar
• Zamora-Ros, R., C. Andres-Lacueva, R. M. Lamuela-Raventós, T. Berenguer, P. Jakszyn, C. Martínez, M. J. Sánchez, C. Navarro, M. D. Chirlaque, M. J. Tormo, J. R. Quirós, P. Amiano, M. Dorronsoro, N. Larrañaga, A. Barricarte, E. Ardanaz, and C. A. González. 2008. Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort. Br. J. Nutr. 100:188–196.
   PubMed Web of Science ®Google Scholar
• Zamora-Ros, R., M. Urpí-Sardà, R. M. Lamuela-Raventós, R. Estruch, M. A. Martínez-González, M. Bulló, F. Aròs, A. Cherubini, and C. Andres-Lacueva. 2009. Resveratrol metabolites in urine as a biomarker of wine intake in free-living subjects: The PREDIMED Study. Free Radic. Biol. Med. 46:1562–1566.
   PubMed Web of Science ®Google Scholar
• Zamora-Ros, R., M. Urpi-Sarda, R. M. Lamuela-Raventós, M. A. Martínez-González, J. Salas-Salvadó, F. Arós, M. Fitó, J. Lapetra, R. Estruch, and C. Andres-Lacueva. 2012. High urinary levels of resveratrol metabolites are associated with a reduction in the prevalence of cardiovascular risk factors in high-risk patients. Pharmacological Research 65:615–620.
   PubMed Web of Science ®Google Scholar
• Zhu, W., W. Qin, K. Zhang, G. E. Rottinghaus, Y. C. Chen, B. Kliethermes, and E. R. Sauter. 2012. Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer. Nutr Cancer. 64:393–400.
   PubMed Web of Science ®Google Scholar
• Zortea, K., V. C. Franco, L. P. Francesconi, K. M. Cereser, M. I. Lobato, and P. S. Belmonte-de-Abreu. 2016. Resveratrol supplementation in schizophrenia patients: a randomized clinical trial evaluating serum glucose and cardiovascular risk factors. Nutrients 8:73.
   PubMed Web of Science ®Google Scholar